Enzalutamide and Cabazitaxel in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer

Clinical trial NCT02522715 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT02522715
Sponsor: OHSU Knight Cancer Institute
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Castration-Resistant Prostate Carcinoma Metastatic Prostate Carcinoma Recurrent Prostate Carcinoma Stage IV Prostate Cancer AJCC v7

Start date: 2015-08-13
Primary completion: 2019-10-16
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.